Jim Cramer’s Recent Takes on These 12 Stocks
“I'm talking about the extreme dichotomy between focusing on a body of wisened economists who are being pushed around by a president who wants to run the central bank and focusing on the free ruling...
Lenz Therapeutics Inc. (LENZ)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Squarepoint Ops LLC Maxime Fortin (Cio) | 0 | $0 | 0% | |
| 2. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 0 | $0 | 0% | |
| 3. | Samsara BioCapital Srini Akkaraju And Michael Dybbs | 0 | $0 | 0% | |
| 4. | Prosight Capital Lawrence Hawkins | 0 | $0 | 0% | |
| 5. | Millennium Management Israel Englander | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.68 | 3,188 | $49,987.84 | 3,188 | 2024-05-14 | Filing | |
| $15.99 | 31,332 | $501,092.68 | 525,565 | 2024-05-13 | Filing | |
| $15.03 | 64,971 | $976,514.13 | 694,755 | 2024-03-21 | Filing | |
| $15.03 | 933,038 | $14,023,561.14 | 3,319,339 | 2024-03-21 | Filing | |
| $4.08 | 350,000 | $1,428,000.00 | 8,459,314 | 2022-04-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $47.01 | 123 | $5,782.64 | 764,127 | 2025-09-30 | Filing | |
| $47.01 | 177 | $8,321.35 | 1,050,599 | 2025-09-30 | Filing | |
| $46.41 | 57,502 | $2,668,483.81 | 764,250 | 2025-09-30 | Filing | |
| $46.41 | 83,066 | $3,854,827.25 | 1,050,776 | 2025-09-30 | Filing | |
| $45.35 | 34,405 | $1,560,428.45 | 821,752 | 2025-09-30 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Q1 2025 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the LENZ Therapeutics First Quarter 2025 Financial Results Conference Call. At this time all participants are in a listen-only mode.
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Q4 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the LENZ Therapeutics Year End 2024 Financial Results Conference Call. This time all participants are in a listen-only mode.
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Q3 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the LENZ Therapeutics' Third Quarter 2024 Conference Call. At this time, all participants are in a listen-only mode.
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Q2 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the LENZ Therapeutics Second Quarter 2024 Conference Call. At this time, all participants are in a listen-only mode.
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Q1 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to LENZ Therapeutics First Quarter 2024 Financial Results and Business Update.
Hedge Fund Resource Center Billionaire Hedge Funds
